Exelixis (EXEL) Reports In-Line Q4 EPS, Slight Miss on Revenues
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
Tweet
Share
E-mailGet Alerts EXEL Hot Sheet
Price: $65.31 +1.13%
EPS Growth %: +11.5%
Financial Fact:
Restructuring charge: 1.02M
Today's EPS Names:
ORPB, PBCO, SICP, More
EPS Growth %: +11.5%
Financial Fact:
Restructuring charge: 1.02M
Today's EPS Names:
ORPB, PBCO, SICP, More
Join SI Premium – FREE
Exelixis (NASDAQ: EXEL) reported Q4 EPS of $0.12, in-line with the analyst estimate of $0.12. Revenue for the quarter came in at $120.1 million versus the consensus estimate of $120.25 million.
- Total Revenue of $120.1 million for the Fourth Quarter of 2017, $452.5 million for the Full Year 2017
- Cabozantinib Franchise Net Product Revenue of $95.7 million for the Fourth Quarter of 2017, $349.0 million for the Full Year 2017
- Diluted EPS of $0.12 per Share for the Fourth Quarter of 2017, $0.49 for the Full Year 2017
For earnings history and earnings-related data on Exelixis (EXEL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- First Bank (FRBA) Tops Q3 EPS by 5c
- Bloom Energy shares fall despite beating Q3 estimates
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
